Chemomab Therapeutics Ltd. - CMMB
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$602K
QoQ value delta ($000)
-$420K
(-41.1%)
Implied price effect (QoQ)
-37.42%
Shares
Total shares
367,379
QoQ shares delta
-22,931
(-5.88%)
Total shares held by funds (by quarter)
Market chart (CMMB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 171 | 103,781 | 0.0% |
| ADAR1 Capital Management, LLC | 132 | 80,000 | 0.01% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 85 | 51,710 | 0.0% |
| Ikarian Capital, LLC | 85 | 51,793 | 0.01% |
| XTX Topco Ltd | 31 | 19,013 | 0.0% |
| RHUMBLINE ADVISERS | 29 | 17,856 | 0.0% |
| JANE STREET GROUP, LLC | 25 | 15,598 | 0.0% |
| Virtu Financial LLC | 18 | 10,933 | 0.0% |
| BNP PARIBAS FINANCIAL MARKETS | 13 | 8,125 | 0.0% |
| MORGAN STANLEY | 6 | 3,775 | 0.0% |
| GAMMA Investing LLC | 4 | 2,514 | 0.0% |
| UBS Group AG | 3 | 2,253 | 0.0% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0 | 2 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 26 | 0.0% |